Azelnidipine (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0123524-52-7
Chemical Formula
C33-H34-N4-O6
Molecular Weight
583
Therapeutic Categories
Antihypertensive agent
Calcium channel blocker
Chemical Name
3-[1-(diphenylmetyl)-3-azetidinyl] 5-isopropyl (±)-2-amino-1,4-dihydro-6-metyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate (WHO)
Foreign Names
- Azelnidipinum (Latin)
- Azelnidipin (German)
- Azelnidipine (French)
- Azelnidipino (Spanish)
Generic Names
- Azelnidipine (OS: JAN)
- CS-905 (IS)
- GJ0956 (IS)
- RS-9054 (IS)
- UNII-PV23P19YUG (IS)
- Azelnidipine (PH: JP XVII)
Brand Names
- Azelnidipine
Fujifilm Pharma, Japan; Kowa Souyaku, Japan; Nichi-Iko Pharmaceutical, Japan; Nihon Generic, Japan; Nippon Chemiphar, Japan; Tanabe Mitsubishi Pharma, Japan; Tatsumi Kagaku, Japan; Teva Pharmaceutical, Japan; Towa Yakuhin, Japan; Yoshindo, Japan; Nipro Pharma Nipurofama, Japan - Beiqi
Chia Tai Tianqing Pharmaceutical, China - Calblock
Daiichi Sankyo, Japan - Rezaltas HD [+ Olmesartan Medoxomil]
Daiichi Sankyo, Japan - Rezaltas LD [+ Olmesartan Medoxomil]
Daiichi Sankyo, Japan
Glossary
Term | Definition |
---|---|
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.